Cargando…

Gestational diabetes and adverse perinatal outcomes from 716,152 births in France in 2012

AIMS/HYPOTHESIS: The aim of this study was to assess the risk of adverse perinatal outcomes in gestational diabetes mellitus (GDM) in a large national cohort. METHODS: All deliveries taking place after 22 weeks in France in 2012 were included by extracting data from the hospital discharge database a...

Descripción completa

Detalles Bibliográficos
Autores principales: Billionnet, Cécile, Mitanchez, Delphine, Weill, Alain, Nizard, Jacky, Alla, François, Hartemann, Agnès, Jacqueminet, Sophie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6518373/
https://www.ncbi.nlm.nih.gov/pubmed/28197657
http://dx.doi.org/10.1007/s00125-017-4206-6
_version_ 1783418441357590528
author Billionnet, Cécile
Mitanchez, Delphine
Weill, Alain
Nizard, Jacky
Alla, François
Hartemann, Agnès
Jacqueminet, Sophie
author_facet Billionnet, Cécile
Mitanchez, Delphine
Weill, Alain
Nizard, Jacky
Alla, François
Hartemann, Agnès
Jacqueminet, Sophie
author_sort Billionnet, Cécile
collection PubMed
description AIMS/HYPOTHESIS: The aim of this study was to assess the risk of adverse perinatal outcomes in gestational diabetes mellitus (GDM) in a large national cohort. METHODS: All deliveries taking place after 22 weeks in France in 2012 were included by extracting data from the hospital discharge database and the national health insurance system. The diabetic status of mothers was determined by the use of glucose-lowering agents and by hospital diagnosis. Outcomes were analysed according to the type of diabetes and, in the GDM group, whether or not diabetes was insulin-treated. RESULTS: The cohort of 796,346 deliveries involved 57,629 (7.24%) mothers with GDM. Mother–infant linkage was obtained for 705,198 deliveries. The risks of adverse outcomes were much lower with GDM than with pregestational diabetes. After limiting the analysis to deliveries after 28 weeks to reduce immortal time bias, the risks of preterm birth (OR 1.3 [95% CI 1.3, 1.4]), Caesarean section (OR 1.4 [95% CI 1.4, 1.4]), pre-eclampsia/eclampsia (OR 1.7 [95% CI 1.6, 1.7]), macrosomia (OR 1.8 [95% CI 1.7, 1.8]), respiratory distress (OR 1.1 [95% CI 1.0, 1.3]), birth trauma (OR 1.3 [95% CI 1.1, 1.5]) and cardiac malformations (OR 1.3 [95% CI 1.1, 1.4]) were increased in women with GDM compared with the non-diabetic population. Higher risks were observed in women with insulin-treated GDM than those with diet-treated GDM. After limiting the analysis to term deliveries, an increased risk of perinatal mortality was observed. After excluding women suspected to have undiagnosed pregestational diabetes, the risk remained moderately increased only for those with diet-treated GDM (OR 1.3 [95% CI 1.0, 1.6]). CONCLUSIONS/INTERPRETATION: GDM is associated with a moderately increased risk of adverse perinatal outcomes, which is higher in insulin-treated GDM than in non-insulin-treated GDM for most outcomes. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s00125-017-4206-6) contains peer-reviewed but unedited supplementary material, which is available to authorised users.
format Online
Article
Text
id pubmed-6518373
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-65183732019-06-05 Gestational diabetes and adverse perinatal outcomes from 716,152 births in France in 2012 Billionnet, Cécile Mitanchez, Delphine Weill, Alain Nizard, Jacky Alla, François Hartemann, Agnès Jacqueminet, Sophie Diabetologia Article AIMS/HYPOTHESIS: The aim of this study was to assess the risk of adverse perinatal outcomes in gestational diabetes mellitus (GDM) in a large national cohort. METHODS: All deliveries taking place after 22 weeks in France in 2012 were included by extracting data from the hospital discharge database and the national health insurance system. The diabetic status of mothers was determined by the use of glucose-lowering agents and by hospital diagnosis. Outcomes were analysed according to the type of diabetes and, in the GDM group, whether or not diabetes was insulin-treated. RESULTS: The cohort of 796,346 deliveries involved 57,629 (7.24%) mothers with GDM. Mother–infant linkage was obtained for 705,198 deliveries. The risks of adverse outcomes were much lower with GDM than with pregestational diabetes. After limiting the analysis to deliveries after 28 weeks to reduce immortal time bias, the risks of preterm birth (OR 1.3 [95% CI 1.3, 1.4]), Caesarean section (OR 1.4 [95% CI 1.4, 1.4]), pre-eclampsia/eclampsia (OR 1.7 [95% CI 1.6, 1.7]), macrosomia (OR 1.8 [95% CI 1.7, 1.8]), respiratory distress (OR 1.1 [95% CI 1.0, 1.3]), birth trauma (OR 1.3 [95% CI 1.1, 1.5]) and cardiac malformations (OR 1.3 [95% CI 1.1, 1.4]) were increased in women with GDM compared with the non-diabetic population. Higher risks were observed in women with insulin-treated GDM than those with diet-treated GDM. After limiting the analysis to term deliveries, an increased risk of perinatal mortality was observed. After excluding women suspected to have undiagnosed pregestational diabetes, the risk remained moderately increased only for those with diet-treated GDM (OR 1.3 [95% CI 1.0, 1.6]). CONCLUSIONS/INTERPRETATION: GDM is associated with a moderately increased risk of adverse perinatal outcomes, which is higher in insulin-treated GDM than in non-insulin-treated GDM for most outcomes. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s00125-017-4206-6) contains peer-reviewed but unedited supplementary material, which is available to authorised users. Springer Berlin Heidelberg 2017-02-15 2017 /pmc/articles/PMC6518373/ /pubmed/28197657 http://dx.doi.org/10.1007/s00125-017-4206-6 Text en © The Author(s) 2017 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Article
Billionnet, Cécile
Mitanchez, Delphine
Weill, Alain
Nizard, Jacky
Alla, François
Hartemann, Agnès
Jacqueminet, Sophie
Gestational diabetes and adverse perinatal outcomes from 716,152 births in France in 2012
title Gestational diabetes and adverse perinatal outcomes from 716,152 births in France in 2012
title_full Gestational diabetes and adverse perinatal outcomes from 716,152 births in France in 2012
title_fullStr Gestational diabetes and adverse perinatal outcomes from 716,152 births in France in 2012
title_full_unstemmed Gestational diabetes and adverse perinatal outcomes from 716,152 births in France in 2012
title_short Gestational diabetes and adverse perinatal outcomes from 716,152 births in France in 2012
title_sort gestational diabetes and adverse perinatal outcomes from 716,152 births in france in 2012
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6518373/
https://www.ncbi.nlm.nih.gov/pubmed/28197657
http://dx.doi.org/10.1007/s00125-017-4206-6
work_keys_str_mv AT billionnetcecile gestationaldiabetesandadverseperinataloutcomesfrom716152birthsinfrancein2012
AT mitanchezdelphine gestationaldiabetesandadverseperinataloutcomesfrom716152birthsinfrancein2012
AT weillalain gestationaldiabetesandadverseperinataloutcomesfrom716152birthsinfrancein2012
AT nizardjacky gestationaldiabetesandadverseperinataloutcomesfrom716152birthsinfrancein2012
AT allafrancois gestationaldiabetesandadverseperinataloutcomesfrom716152birthsinfrancein2012
AT hartemannagnes gestationaldiabetesandadverseperinataloutcomesfrom716152birthsinfrancein2012
AT jacqueminetsophie gestationaldiabetesandadverseperinataloutcomesfrom716152birthsinfrancein2012